Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model

被引:5
|
作者
Khalili, Dilan [1 ]
Kalcher, Christina [1 ]
Baumgartner, Stefan [2 ]
Theopold, Ulrich [1 ]
机构
[1] Stockholm Univ, Wenner Gren Inst MBW, Dept Mol Biosci, Stockholm, Sweden
[2] Lund Univ, Dept Expt Med Sci, Lund, Sweden
基金
瑞典研究理事会;
关键词
Fibrosis; Antimicrobial peptides; Insect immunity; Innate immunity; Extracellular matrix;
D O I
10.1159/000516104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fibrotic lesions accompany several pathological conditions, including tumors. We show that expression of a dominant-active form of the Ras oncogene in Drosophila salivary glands (SGs) leads to redistribution of components of the basement membrane (BM) and fibrotic lesions. Similar to several types of mammalian fibrosis, the disturbed BM attracts clot components, including insect transglutaminase and phenoloxidase. SG epithelial cells show reduced apicobasal polarity accompanied by a loss of secretory activity. Both the fibrotic lesions and the reduced cell polarity are alleviated by ectopic expression of the antimicrobial peptide drosomycin (Drs), which also restores the secretory activity of the SGs. In addition to extracellular matrix components, both Drs and F-actin localize to fibrotic lesions.
引用
收藏
页码:376 / 390
页数:15
相关论文
共 50 条
  • [21] Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
    Vanderstichele, Sophie
    Vranckx, Jan Jeroen
    WORLD JOURNAL OF STEM CELLS, 2022, 14 (02): : 200 - 213
  • [22] Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
    Iwata, Yasunori
    Sakai, Norihiko
    Nakajima, Yuki
    Oshima, Megumi
    Nakagawa-Yoneda, Shiori
    Ogura, Hisayuki
    Sato, Koichi
    Minami, Taichiro
    Kitajima, Shinji
    Toyama, Tadashi
    Yamamura, Yuta
    Miyagawa, Taro
    Hara, Akinori
    Shimizu, Miho
    Furuichi, Kengo
    Wada, Takashi
    BMC NEPHROLOGY, 2021, 22 (01)
  • [23] Synthesis and evaluation of asiatic acid derivatives as anti-fibrotic agents: Structure/activity studies
    Li, Yong
    Yang, Fang
    Yuan, Mingxing
    Jiang, Lijuan
    Yuan, Li
    Zhang, Xiaowei
    Li, Ying
    Dong, Lin
    Bao, Xu
    Yin, Shufan
    STEROIDS, 2015, 96 : 44 - 49
  • [24] Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target
    Marangoni, Roberta G.
    Masui, Yuri
    Fang, Feng
    Korman, Benjamin
    Lord, Gabriel
    Lee, Junghwa
    Lakota, Katja
    Wei, Jun
    Scherer, Philipp E.
    Otvos, Laszlo
    Yamauchi, Toshimasa
    Kubota, Naoto
    Kadowaki, Takashi
    Asano, Yoshihide
    Sato, Shinichi
    Tourtellotte, Warren G.
    Varga, John
    SCIENTIFIC REPORTS, 2017, 7
  • [25] Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin
    Kim, Hyun Young
    Otgontenger, Undarmaa
    Kim, Jun-Woo
    Lee, Young Joo
    Kim, Sang-Bum
    Lim, Sung Chul
    Kim, Young-Mi
    Kang, Keon Wook
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (03) : 149 - 159
  • [26] Criteria to select molecular targets for anti-fibrotic therapy
    Distler, J. H. W.
    Distler, O.
    RHEUMATOLOGY, 2008, 47 : V12 - V13
  • [27] Fibrin glue: an anti-fibrotic agent for contracted socket
    Saputro, Ivon Bremmy Wydha
    Primitasari, Yulia
    Fatmariyanti, Susy
    Fauziah, Dyah
    Utomo, Budi
    BALI MEDICAL JOURNAL, 2022, 11 (03) : 1498 - 1502
  • [28] Pirfenidone: an anti-fibrotic therapy for progressive kidney disease
    Cho, Monique E.
    Kopp, Jeffrey B.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (02) : 275 - 283
  • [29] Role of endothelin in fibrosis and anti-fibrotic potential of bosentan
    Clozel, M
    Salloukh, H
    ANNALS OF MEDICINE, 2005, 37 (01) : 2 - 12
  • [30] Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy
    Zhang, Zequn
    Liu, Xi
    Shen, Zhaolong
    Quan, Jun
    Lin, Changwei
    Li, Xiaorong
    Hu, Gui
    DRUG DELIVERY, 2021, 28 (01) : 2051 - 2061